The Catheter-Related Bloodstream Infection Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for catheter-related bloodstream infection has been experiencing significant growth. In 2024, it was valued at $1.53 billion and is projected to reach $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%.
The Catheter-Related Bloodstream Infection market is anticipated to reach a value of $2.05 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Catheter-Related Bloodstream Infection Market Report and Uncover Key Trends Now!The drivers in the catheter-related bloodstream infection market are:
• Rising incidence of chronic diseases
• Increased awareness and education
• Surge in hospital-acquired infections
• Enhanced infection control programs in medical facilities and an aging population
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The trends in the catheter-related bloodstream infection market are:
• Biomaterial innovations are a major emerging trend in the catheter-related bloodstream infection market.
• Smart catheter technology is increasingly shaping the future of this market.
• The development of catheter lock solutions with advanced antimicrobial properties is an important upcoming trend.
• Innovations in sterilization processes for catheters and automated flushing systems are significantly influencing the market.
The major players in the catheter-related bloodstream infection market are:
• Pfizer Inc.
North America was the largest region in the catheter-related bloodstream infection market in 2023